戻る Agenda
[V3-S5] Multi-Regional Clinical Trials: Where Should it Be Headed?
Session Chair(s)
Hironobu Saito, PHD
Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan
Speaker(s)
Advancing Roles of Japan on Global Drug Development
Yoshiaki Uyama, PHD, MS, RPH
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Proposal for Interpreting the Resuts from MRCT and Its Reflection onto the MRCT Planning
Osamu Komiyama
Pfizer R&D Japan G.K., Japan
Senior Manager, Statistical Research & Data Science